Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis harrisbricken Views: 379

A bill (369/2021) to allow veterinarians to prescribe cannabis products has been introduced in Brazil’s Chamber of Deputies. Under the terms of the bill, products must be authorized by the Brazilian regulatory authorities or, in the case of imported products, their counterparts in the country of origin. If the government does not issue specific regulations for veterinary products, the bill provides that products must follow existing rules for human-use products.

As the bill’s statement of motives explains, many Brazilian vets are already prescribing cannabis products. At the moment, veterinary use of cannabis products is neither allowed nor prohibited. The bill seeks to end this “legal limbo,” as it describes the situation.

The bill’s sponsor is Deputy João Carlos Bacelar, of the Podemos party. Interestingly, Podemos is not generally pro-cannabis. As recently as August 2020, Podemos Senator Eduardo Girão described as an “aberration” a separate medical cannabis bill (399/2015), adding that “maconha is a drug that destroys families.” In his view, treating epilepsy is an excuse to normalize cannabis in Brazil, at the behest of the narcobusiness (narconegócio) lobby. (Girão does support the regulatory approval of specific medicines that contain cannabis). For his part, Podemos Deputy Diego Garcia referred to the bill “a Trojan horse” for recreational cannabis.

Despite Podemos’ hostility, the medical cannabis bill continues its lengthy path to approval (yes, 2015 stands for the year when it was introduced). A new version of the proposed law would allow medical cannabis and industrial hemp cultivation in Brazil, with the aim of increasing supply. The prescription of cannabis products for medical use has been authorized since 2014, yet cultivation remains illegal. Reliance on imports makes costs prohibitive for large segments of the Brazilian population, according to Deputy Pablo Teixeira, who presides the commission evaluating the bill. However, the COVID-19 pandemic and municipal elections have delayed the commission’s evaluation of the replacement text.

Home cultivation would not be permitted under the bill, but it is worth noting that courts have been granting habeas corpus petitions from citizens seeking to grow their own cannabis. For example, in March 2020, a federal judge in Pernambuco granted a habeas writ to a woman who sought to make her own cannabis oil to treat her son’s seizures. In February 2021, a São Paulo judge granted the first collective habeas, to an association of 21 families. It will be interesting to see if this trend leads to judicial decisions of broader application.

Cannabis for Brazilian Pets and Their Humans on Harris Bricken.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.